Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) has participated in 2 clinical trials.
Therapeutic areas: EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer.
Sponsors: Daiichi Sankyo.
Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) has 2 clinical trials on record. Their work covers EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer.
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.